Clinical Features, Treatment Mode and Health Outcomes of Chest Pain Patients in China (CHANGE)
CHANGE
1 other identifier
observational
50,000
0 countries
N/A
Brief Summary
Chinese Cardiovascular Association is an association dedicated to establishing Chest Pain Centers in hospitals that have basic qualifications and meet pre-designed quality control targets.The vision of Chinese Cardiovascular Association is the cardiovascular health of every Chinese, and the mission is to realize the early arrival of the inflection point of cardiovascular events in China.The institute of China Heart House is responsible for the daily management and implementation of Chinese Cardiovascular Association and the implementation and management of the Chest Pain Center construction project.In order to improve standard treatment and chest pain system management to achieve better outcomes for patients, China Heart House established the chest pain center database.The database includes patients in 4129 registered hospitals in 31 provinces in China who have been admitted with chest pain.The database can reflect the clinical characteristics, treatment and outcome of patients with chest pain in China. This non-interventional, retrospective study analyzed the chest pain center database to understand the demographics, clinical characteristics, treatment patterns and clinical outcomes of patients with chest pain, and to analyze the effects of different treatment patterns, including chest pain centers and related collaborative treatment networks.The results of the study will assess the gap between the real-world situation and the recommendations of the guidelines and reflect the effect of chest pain centers and related collaborative treatment networks on the treatment process and service quality.The research results can be directly translated into the basis of medical treatment system intervention, and also provide decision-making reference for improving the certification standards and quality control of chest pain centers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2019
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2019
CompletedFirst Submitted
Initial submission to the registry
July 3, 2019
CompletedFirst Posted
Study publicly available on registry
July 10, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2019
CompletedJuly 10, 2019
July 1, 2019
1 month
July 3, 2019
July 9, 2019
Conditions
Outcome Measures
Primary Outcomes (8)
mean and standard deviation of STEMI (ST-segment elevated Myocardial Infarction)patients
mean and standard deviation of STEMI patients
baseline
Proportion of STEMI (ST-segment elevated Myocardial Infarction)patients
Proportion of female STEMI patients
baseline
emergency information of STEMI patients
Path to hospital First medical contact time Does the patient circumvent emergency Telecardiogram transmission STEMI Reperfusion Therapy Initiation time of interventional surgery Catheter chamber activation time Time of arrival of patient in catheter room Guide wire passage time D2B time
baseline
admission status of STEMI patients
admission status of STEMI patients
baseline
hospitalization evaluation of STEMI patients
value of serum troponin and serum creatinin of STEMI patients
baseline
In-hospital mortality of STEMI patients
In-hospital mortality of STEMI patients
baseline
Hospitalization days of STEMI patients
Hospitalization days of STEMI patients
baseline
Total cost of STEMI patients
Total cost of STEMI patients
baseline
Study Arms (1)
Patients with Myocardial Infarction
Eligibility Criteria
The study population was inpatients (18 years and older) admitted to the Chest Pain Central database with symptoms of chest pain.The database registration of this study was conducted in 4129 registered hospitals in 31 provinces in China.All hospitals participating in the Chest Pain Center program are encouraged to manage patients in accordance with local standard practices (as recommended by current Chinese guidelines). This study will include data on all patients in the chest pain central database.
You may qualify if:
- age 18 and above
- patients admitted with chest pain
- diagnosis is made by the treating physician based on local practice and clinical judgment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- China Cardiovascular Associationlead
- Peking University First Hospitalcollaborator
- Shanghai Zhongshan Hospitalcollaborator
- Peking Universitycollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 3, 2019
First Posted
July 10, 2019
Study Start
July 1, 2019
Primary Completion
August 1, 2019
Study Completion
August 1, 2019
Last Updated
July 10, 2019
Record last verified: 2019-07